Analysts Set HCA Healthcare Inc (NYSE:HCA) Price Target at $149.00

HCA Healthcare Inc (NYSE:HCA) has been given a consensus rating of “Buy” by the twenty-three research firms that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and eighteen have given a buy rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $149.41.

HCA has been the topic of a number of recent research reports. ValuEngine cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, March 6th. Barclays cut their price objective on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating on the stock in a report on Wednesday, April 17th. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the stock a “buy” rating in a report on Wednesday, April 17th. Raymond James upgraded shares of HCA Healthcare from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $115.00 to $135.00 in a report on Tuesday, April 23rd. Finally, Deutsche Bank upped their price objective on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a report on Wednesday, May 1st.

Shares of NYSE HCA traded down $2.52 during midday trading on Friday, hitting $132.66. 32,579 shares of the company traded hands, compared to its average volume of 1,463,626. HCA Healthcare has a 12-month low of $101.30 and a 12-month high of $147.42. The firm has a 50-day moving average of $125.84. The company has a market capitalization of $44.87 billion, a price-to-earnings ratio of 13.55, a P/E/G ratio of 1.05 and a beta of 0.76.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The company had revenue of $12.52 billion for the quarter, compared to analysts’ expectations of $12.34 billion. During the same quarter in the previous year, the company earned $3.18 earnings per share. HCA Healthcare’s quarterly revenue was up 9.6% on a year-over-year basis. As a group, analysts expect that HCA Healthcare will post 10.4 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.21%. HCA Healthcare’s dividend payout ratio is presently 16.38%.

In other news, insider Jon M. Foster sold 44,281 shares of the company’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $122.28, for a total value of $5,414,680.68. Following the transaction, the insider now owns 96,052 shares in the company, valued at $11,745,238.56. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.70% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Amundi Pioneer Asset Management Inc. lifted its position in HCA Healthcare by 2.3% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,290,505 shares of the company’s stock valued at $168,257,000 after purchasing an additional 28,925 shares during the period. Horizon Investments LLC bought a new position in HCA Healthcare during the first quarter valued at approximately $206,000. Nordea Investment Management AB lifted its position in HCA Healthcare by 24.7% during the first quarter. Nordea Investment Management AB now owns 376,630 shares of the company’s stock valued at $49,105,000 after purchasing an additional 74,713 shares during the period. Advisory Services Network LLC lifted its position in HCA Healthcare by 32.1% during the first quarter. Advisory Services Network LLC now owns 5,067 shares of the company’s stock valued at $661,000 after purchasing an additional 1,231 shares during the period. Finally, Cerebellum GP LLC lifted its position in HCA Healthcare by 27.1% during the first quarter. Cerebellum GP LLC now owns 2,560 shares of the company’s stock valued at $334,000 after purchasing an additional 546 shares during the period. Hedge funds and other institutional investors own 70.23% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: What are no-load funds?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.